期刊
PHYSIOLOGICAL RESEARCH
卷 71, 期 1, 页码 147-157出版社
ACAD SCIENCES CZECH REPUBLIC, INST PHYSIOLOGY
DOI: 10.33549/physiolres.934800
关键词
Experimental autoimmune encephalomyelitis; Edaravone; Mitochondrial dysfunction; Nrf2/HO-1 pathway; Oxidative stress
类别
资金
- MH CZ-DRO (General University Hospital in Prague) [VFN 00064165]
- Charles University Project Progres Q25
- Czech Science Foundation [17-07332S, 20-09732S]
- Charles University Project Progres Q27
The aim of this study was to evaluate the therapeutic potential and mechanism of action of edaravone in a murine model of multiple sclerosis, experimental autoimmune encephalomyelitis (EAE). The results showed that edaravone treatment ameliorated EAE severity, attenuated inflammation, decreased oxidative stress, increased the gene expression of Nrf2 and HO-1, increased the activity of the mitochondrial complex IV, and preserved ATP production in the spinal cords of EAE mice. These findings provide additional evidence of the potential of edaravone for the treatment of multiple sclerosis and expand our knowledge of its mechanism of action in the EAE model.
The aim of this study was to evaluate therapeutic potential of edaravone in the murine model of multiple sclerosis, experimental autoimmune encephalomyelitis (EAE) and to expand the knowledge of its mechanism of action. Edaravone (6 mg/kg/day) was administered intraperitoneally from the onset of clinical symptoms until the end of the experiment (28 days). Disease progression was assessed daily using severity scores. At the peak of the disease, histological analyses, markers of oxidative stress (OS) and parameters of mitochondria! function in the brains and spinal cords (SC) of mice were determined. Gene expression of inducible nitric oxide synthase (iNOS), nuclear factor erythroid 2-related factor 2 (Nrf2), heme oxygenase-1 (HO-1) and peroxisome proliferator-activated receptor-gamma coactivator (PGC)-'alpha was determined at the end of the experiment. Edaravone treatment ameliorated EAE severity and attenuated inflammation in the SC of the EAE mice, as verified by histological analysis. Moreover, edaravone treatment decreased OS, increased the gene expression of the Nrf2 and HO-1, increased the activity of the mitochondrial complex reduced the activity of the mitochondrial complex IV and preserved ATP production in the SC of the EAE mice. In conclusion, findings in this study provide additional evidence of edaravone potential for the treatment of multiple sclerosis and expand our knowledge of the mechanism of action of edaravone in the EAE model.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据